Real-world outcomes after anifrolumab initiation in systemic lupus erythematosus: a pragmatic treat-to-target analysis.
D. Núñez
Paloma Camarero Diaz
Sara Rodríguez Montes
C. M. Prada
C. L. Petisco
L. Abasolo
B. Gutiérrez
Medicine